Today, RTI President John Robertson announced the spin-off of divisions that will focus separately on human and animal health problems and solutions to these problems.  The new human medical division will be called UroLog-X™ LLC and the animal health division will be called VetUroLog-X™ LLC.  Both divisions will utilize patented RTI technologies and devices, based on the Rametrix® computational platform.

With 2025 seeing the commercialization and first sales of RTI computational and analytical

technology, separating product development focused on the human and animal health markets was a logical step in the evolution of Rametrix Technologies, Inc. “We look forward to continued success in introducing novel solutions to health problems for both ‘two-legged’ and ‘four-legged’ patients,” said Robertson.  “The future is bright and we feel the next two years will show the value of our approaches, in alleviating suffering and improving outcomes in our two areas of focus: cancer and renal disease.”